These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10612569)

  • 1. Expression of transforming growth factor-beta1 and tumour necrosis factor-alpha in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin.
    Maeda A; Ishioka S; Taooka Y; Hiyama K; Yamakido M
    Respirology; 1999 Dec; 4(4):359-63. PubMed ID: 10612569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice.
    Maeda A; Hiyama K; Yamakido H; Ishioka S; Yamakido M
    Chest; 1996 Mar; 109(3):780-6. PubMed ID: 8617091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis.
    Gurujeyalakshmi G; Hollinger MA; Giri SN
    Am J Respir Cell Mol Biol; 1998 Mar; 18(3):334-42. PubMed ID: 9490651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
    Andreutti D; Gabbiani G; Neuville P
    Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.
    Takemasa A; Ishii Y; Fukuda T
    Eur Respir J; 2012 Dec; 40(6):1475-82. PubMed ID: 22441751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell-derived transforming growth factor-beta in bleomycin-induced pulmonary injury.
    Kumar RK; O'Grady R; Maronese SE; Wilson MR
    Int J Exp Pathol; 1996 Jun; 77(3):99-107. PubMed ID: 8774378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of signal transducer and activator of transcription 1 antisense oligodeoxynucleotides on inflammatory mediators, type I and type III collagen mRNA of rat pulmonary fibrosis].
    Wang WJ; Zeng M; Liu D; Fan XM; Zhu C; Zhan XQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):389-92. PubMed ID: 19426591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proapoptotic Bid is required for pulmonary fibrosis.
    Budinger GR; Mutlu GM; Eisenbart J; Fuller AC; Bellmeyer AA; Baker CM; Wilson M; Ridge K; Barrett TA; Lee VY; Chandel NS
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4604-9. PubMed ID: 16537427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice.
    Hirata H; Arima M; Fukushima Y; Sugiyama K; Tokuhisa T; Fukuda T
    Respirology; 2013 May; 18(4):674-81. PubMed ID: 23432979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice].
    Liu M; Gou S; Chen HT; Chen ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):509-514. PubMed ID: 28752966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
    Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
    J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of combination of Salvia and Ligustrazine on TNF-α and TGF-β1 in serum and BALF of rats with pulmonary fibrosis].
    Huang C; Li Y; Fan X; Wang W; Zhan X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):673-6. PubMed ID: 23837972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis.
    Matsuoka H; Arai T; Mori M; Goya S; Kida H; Morishita H; Fujiwara H; Tachibana I; Osaki T; Hayashi S
    Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L103-12. PubMed ID: 12060566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice.
    Taooka Y; Maeda A; Hiyama K; Ishioka S; Yamakido M
    Am J Respir Crit Care Med; 1997 Jul; 156(1):260-5. PubMed ID: 9230758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
    Otsuka M; Takahashi H; Shiratori M; Chiba H; Abe S
    Thorax; 2004 Jan; 59(1):31-8. PubMed ID: 14694243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.